PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28496202-6	2017	Treatment of cultured PSC with the Jak1/2 inhibitor ruxolitinib reduced STAT3 phosphorylation, cell proliferation, and expression of alpha-smooth muscle actin (alpha-SMA), a marker of PSC activation.	ruxolitinib	52-63	actin alpha 2, smooth muscle, aorta	Mus musculus	133-158	
28496202-6	2017	Treatment of cultured PSC with the Jak1/2 inhibitor ruxolitinib reduced STAT3 phosphorylation, cell proliferation, and expression of alpha-smooth muscle actin (alpha-SMA), a marker of PSC activation.	ruxolitinib	52-63	actin alpha 2, smooth muscle, aorta	Mus musculus	160-169